$LAHO - Yesterdays SEC action with LAHO was a blind side

New Post Public Reply Private Reply Replies (1) Message Board
4 MY T
709
$LAHO - Yesterdays SEC action with LAHO was a blind side surprise to all of us.
https://www.investor.gov/additional-resources...uspensions

After I picked myself up off the floor, I started watching the reactions from the shareholders on the other board. I watched and read every post for 17 hours. I'm on the west coast so that's from 7 a.m. till midnight. I wanted to compile the evidence and consult my pillow last night before making a post.

Here are few things this I noticed.

First is the posts from all the doomsayers that were there all day to try and help us salvage what we could monetarily. All of their posts had a common thread in that LAHO is destined for the grey market and its written in stone and there is nothing anyone can do about it. And that the only thing shareholders can do to try and come out of this with a little money is to sell on the cheap right when LAHO starts trading again. (the sky is falling etc.)

And how would one go about doing that? One would have to set their sell orders now for a low price and try and sell it as soon as LAHO starts trading again. Ask yourself who would gain from that? People wanting cheap shares. And how would that play out? From the link above stating how this works with the SEC, we wont know if LAHO will be on the greys or if it will start trading where it left off until the moment we start trading again. And what would happen if there is a bunch of sell orders pre-set ready to sell on the cheap at the opening bell the moment LAHO starts trading again? Drop in pps price by the mass exodus. Who would benefit from that if LAHO starts trading 10 days from now right where we left off yesterday? hmmmmm.

And like clockwork all the bashers voices, posts and guns all fell silent almost in unison. Just like they do on a down day for LAHO hoping to scare some into selling. I mean eerily similar. Remember the mm's pay bashers to bash a stock that they are trying to hold back.

And then this post came along:
https://investorshub.advfn.com/boards/read_ms...=150974882

This smacks of desperation by an mm. All the paid bashers were there all day yesterday all saying the same thing. hmmmm

There has been instances of mm's literally going broke, I mean out of business broke, due to a short squeeze. And LAHO was right on the cusp of a short squeeze that I believe would have taken it to beyond $.01 before retracing. That would have put the hurt to probably more than one mm. Maybe an mm called in a favor from the SEC to save their rear end.


Second is I spoke with Sean at the auditors office yesterday. He told me that the audit was proceeding as planned regardless of yesterdays SEC action. If this were a scam, why would the company spend the money to finish the audit? It would serve no purpose.

Call them if you like.
Fruci & Associates
Phone: 509 624 9223



Third is look at the company and in particular the CEO:
http://www.lans.holdings/about.html

To me, the numbers don't add up to a scam.

The paid bashers are telling me that the company is going to take the shareholders for a few bucks and throw away the funding they need, via going public, to further their work?

To me, the numbers don't add up to a scam.

The paid bashers are telling me that the company is going to take the shareholders for a few bucks and throw away the future earnings from the shares they own and risk lawsuits up the wazzoo and damage their reputation with the medical community for a few measly bucks by scamming the shareholders?

To me, the numbers don't add up to a scam.

The companies both do their DD well in advance before entering into a binding LOI to have this be more than just a bump in the road. I'll have to see proof of a scam, other than the paid bashers touting it, for me to believe otherwise.

To me, the numbers don't add up to a scam.

Too many paid bashers on the other board yesterday trying to save me from myself by instructing me to get my sell orders in right now for a bargain basement price all in unison for me to believe them. Especially when we wont know how this ends up, grey market or trading as usual, until the very moment LAHO starts trading again.

To me, the numbers don't add up to a scam.


All IMO of course.


P.S. I'm holding my sell orders right where they are at now. I'll hold my cards and wait for the opening bell when LAHO starts trading again before I make any changes. All the paid bashers yesterday were just a little too coincidental for me.

As I am fond of saying "I have heard of a coincidence, I just haven't seen one yet."











Lans Holdings, Inc. (LAHO) Stock Research Links

LAHO Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AtWork Welcomes Franchise Vet Sarah Goehring

Updated Category News Views 17

A Strategic Move for AtWork There's a new heavyweight at AtWork, a name that's been catching attention in the franchise biz lately—Sarah Goehring. This isn't just another appointment; it's a signal flare for AtWork's ambitions. With Goehring, they're doubling down on scaling their operation and drawing in more franchise players who are ready to hit the ground running....

Continue Reading
Partner Valuation Advisors Bolsters Team with Eichman

Updated Category News Views 6

Eichman Joins Partner Valuation Advisors as MD Turns out the buzz in real estate appraisal isn’t just about property values these days; it's about who's valuing them. Just ask Partner Valuation Advisors, who are realigning their chess pieces by bringing seasoned pro Justin Eichman, MAI, on board as Managing Director. Talk about playing your cards right. A Heavyweight in...

Continue Reading
TechCrunch Disrupt 2026: NYSE and Snowflake Highlights

Updated Category News Views 20

Ever noticed how the air vibrates just a bit more when major players like NYSE and Snowflake start shaking hands at big-league events like TechCrunch Disrupt? You'd better believe we're seeing a fresh brew of opportunities and challenges in the market as these titans lock horns and share insights. It's no small feat when the financial nerve center partners into the tech...

Continue Reading
Maven Pet's AI Paw-tnership: Changing Pet Care Landscape

Updated Category News Views 8

AI in the World of Doggie Docs In today's tech-driven world, pet owners are turning to artificial intelligence like never before. Forget flipping through outdated dog-care books—nearly half of us are drilling ChatGPT for health tips on our four-legged pals. Yes, it seems we’re asking an AI about Rover's health more than some other major life decisions. But let's face...

Continue Reading
Franco-Nevada's Q3 Results Loom: Investors Ready

Updated Category News Views 15

Gearing Up: Franco-Nevada's Q3 Numbers on the Horizon You know the drill! Franco-Nevada's third quarter results won't just trickle in—they'll set the tone for the months ahead. Mark your calendar: November 11th after the market closes is the magic hour when you'll get the skinny on their Q3 performance. The next morning, bright and early at 8:00 AM ET, they'll hash it...

Continue Reading
CMC Declares Dividend Amid Complex Outlook

Updated Category News Views 17

Dividend's Not Just a Regular Check October 13, 2026, marks yet another dividend declaration by CMC. This time, they're dishing out $0.20 per share—a steady payday for loyal shareholders. That's 248 times in a row they've done this song and dance. Odds are, folks holding NYSE:CMC shares are giving the nod of approval, but it ain't just about cash; it's about stability...

Continue Reading
Paradigm Therapeutics: A Beacon in Rare Diseases

Updated Category News Views 2

A Step Towards Recognition You know the old saying: innovation never sleeps. Well, Paradigm Therapeutics seems to have taken that to heart. The company's embarked on a peculiar yet promising journey with SD-101 (Zorblesia™), and here they are, basking in the glow of another nomination for the 2026 Prix Galien USA "Best Start-Up" award. It’s their second shot at this...

Continue Reading
New Data on SKYRIZI Offers Hope for Crohn's Patients

Updated Category News Views 12

Treating Crohn's: New Hope on the Horizon Folks, let me tell you, the landscape for treating Crohn's disease just got a bit more interesting. AbbVie's Phase 3 AFFIRM study has brought some attention-grabbing data on the table, showcasing the potential of their drug, SKYRIZI® (risankizumab-rzaa). This ain't just another run-of-the-mill study; these results could be a...

Continue Reading
Laars Welcomes Women in Manufacturing to Facility Tour

Updated Category News Views 6

Opening Doors and Minds in Manufacturing On October 15, Laars Heating Systems throws wide open its Rochester, N.H., facility to a group that's rewriting the rulebook: women in manufacturing. It's not just another day in the life of assembly lines and engineering desks, folks. This is about giving a platform to those often sidelined in the field of boilers and water...

Continue Reading
Home Buying: Unmasking All the Real Budget Costs

Updated Category News Views 2

Home Buying: More Costs Than Meets the Eye Let's face it, buying a home is no stroll in the park. It's a tangled web of numbers and surprises that can leave even the savviest buyer in a daze. Thank goodness for articles like the one from HelloNation featuring Serena LoPiccolo-Smith, which make the invisible visible when it comes to the financial intricacies of home...

Continue Reading
ore News Articles